1,240
Views
18
CrossRef citations to date
0
Altmetric
Commentary

Engineered PRINT® nanoparticles for controlled delivery of antigens and immunostimulants

, , , &
Pages 1908-1913 | Received 26 Mar 2014, Accepted 08 Apr 2014, Published online: 22 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maryam A. Shetab Boushehri, Mona M. A. Abdel-Mottaleb, Arnaud Béduneau, Yann Pellequer & Alf Lamprecht. (2018) A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides. Drug Delivery 25:1, pages 1414-1425.
Read now
Liliana R. Pires, Fernanda Marques, João Carlos Sousa, João Cerqueira & Inês Mendes Pinto. (2016) Nano- and micro-based systems for immunotolerance induction in multiple sclerosis. Human Vaccines & Immunotherapeutics 12:7, pages 1886-1890.
Read now

Articles from other publishers (16)

Keith P. Klugman, Richard Malley & Cynthia G. Whitney. 2023. Plotkin's Vaccines. Plotkin's Vaccines 826 868.e18 .
Surya Prakash Singh & Aravind Kumar Rengan. 2021. Microbial Interactions at Nanobiotechnology Interfaces. Microbial Interactions at Nanobiotechnology Interfaces 167 186 .
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder & Kristy M. Ainslie. (2021) Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases. Advanced NanoBiomed Research 1:3, pages 2000041.
Crossref
Rebeca T. Stiepel, Cole J. Batty, Christopher A. MacRaild, Raymond S. Norton, Eric Bachelder & Kristy M. Ainslie. (2021) Merozoite surface protein 2 adsorbed onto acetalated dextran microparticles for malaria vaccination. International Journal of Pharmaceutics 593, pages 120168.
Crossref
Puneet Tyagi. (2021) Harnessing the nano-bio interface: Application of membrane coating to long acting silica particles. European Journal of Pharmaceutics and Biopharmaceutics 158, pages 382-389.
Crossref
Kathryn M. Moore, Cole J. Batty, Rebeca T. Stiepel, Christopher J. Genito, Eric M. Bachelder & Kristy M. Ainslie. (2020) Injectable, Ribbon-Like Microconfetti Biopolymer Platform for Vaccine Applications. ACS Applied Materials & Interfaces 12:35, pages 38950-38961.
Crossref
Lai Jiang, Hiang Wee Lee & Say Chye Joachim Loo. (2020) Therapeutic lipid-coated hybrid nanoparticles against bacterial infections. RSC Advances 10:14, pages 8497-8517.
Crossref
Danielle S.W. Benoit, Clyde T. Overby, Kenneth R. Sims Jr.Marian A. Ackun-Farmmer. 2020. Biomaterials Science. Biomaterials Science 1237 1266 .
Kathryn R. Stein, Thomas J. Gardner, Rosmel E. Hernandez, Thomas A. Kraus, James A. Duty, Iban Ubarretxena-Belandia, Thomas M. Moran & Domenico Tortorella. (2019) CD46 facilitates entry and dissemination of human cytomegalovirus. Nature Communications 10:1.
Crossref
Peipei Zhang, Junfei Xia & Sida Luo. (2018) Generation of Well-Defined Micro/Nanoparticles via Advanced Manufacturing Techniques for Therapeutic Delivery. Materials 11:4, pages 623.
Crossref
Puneet Tyagi & J. Anand Subramony. (2018) Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small. Journal of Controlled Release 272, pages 159-168.
Crossref
Keith P. Klugman, Ron Dagan, Richard Malley & Cynthia G. Whitney. 2018. Plotkin's Vaccines. Plotkin's Vaccines 773 815.e18 .
Anil B. Jindal. (2017) The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles. International Journal of Pharmaceutics 532:1, pages 450-465.
Crossref
Eli J Curry, Atta D Henoun, Albert N MillerIIIIII & Thanh D Nguyen. (2017) 3D nano- and micro-patterning of biomaterials for controlled drug delivery. Therapeutic Delivery 8:1, pages 15-28.
Crossref
P. Malyala & D.T. O'Hagan. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines 231 248 .
Chintan H. Kapadia, Shaomin Tian, Jillian L. Perry, J. Christopher Luft & Joseph M. DeSimone. (2016) Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs. Molecular Pharmaceutics 13:10, pages 3381-3394.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.